Premium Nahrungsergänzungsmittel | artgerecht

Rapamycin (Sirolimus): Uses, Mechanism & Research

Rapamycin (sirolimus) is an immunosuppressive drug used to prevent organ transplant rejection and is being studied as a potential anti-aging compound.

Regular tips about health Regular tips about health

Things worth knowing about "Rapamycin"

Rapamycin (sirolimus) is an immunosuppressive drug used to prevent organ transplant rejection and is being studied as a potential anti-aging compound.

What is Rapamycin?

Rapamycin, also known by its generic name sirolimus, is a naturally occurring macrolide compound with potent immunosuppressive and antiproliferative properties. It was first isolated in the 1970s from the soil bacterium Streptomyces hygroscopicus, discovered on Easter Island (Rapa Nui) – hence the name rapamycin. Today, it is best known as an mTOR inhibitor and has a broad range of clinical and investigational applications.

Mechanism of Action

Rapamycin works by inhibiting the mechanistic target of rapamycin complex 1 (mTORC1), a central kinase that regulates cell growth, proliferation, metabolism, and autophagy (the process by which cells break down and recycle damaged components).

Rapamycin binds to the intracellular protein FKBP12.
The resulting complex binds to mTORC1, inhibiting its activity.
This leads to reduced T-cell proliferation and a dampened immune response.
Simultaneously, autophagy is enhanced, promoting cellular housekeeping and renewal.

Medical Uses

Organ Transplantation

The primary approved clinical use of rapamycin is the prevention of kidney transplant rejection. It is used in combination with other immunosuppressive agents to prevent the recipient's immune system from attacking the donor organ.

Oncology

Rapamycin analogues (known as rapalogs, such as everolimus and temsirolimus) are approved for treatment of several cancers, including:

Renal cell carcinoma
Hormone receptor-positive, HER2-negative breast cancer
Pancreatic neuroendocrine tumors
Mantle cell lymphoma

Rare Diseases

Everolimus, a rapamycin analogue, is used in tuberous sclerosis complex and lymphangioleiomyomatosis (LAM), conditions in which the mTOR pathway is constitutively overactivated due to genetic mutations.

Rapamycin in Anti-Aging Research

Rapamycin has attracted significant scientific interest as a potential longevity-promoting compound. Animal studies, particularly in mice, have demonstrated that rapamycin can extend lifespan even when administered in middle age. The proposed mechanisms include:

Enhanced autophagy and clearance of damaged cellular components
Slowing of cellular senescence (biological aging of cells)
Reduction of chronic low-grade inflammation (inflammaging)
Improvement of mitochondrial function

Human clinical trials examining anti-aging effects of rapamycin are still in early stages. The PEARL trial is currently investigating potential health benefits of low-dose rapamycin in healthy older adults.

Dosage and Administration

In clinical transplantation settings, rapamycin is administered orally as a tablet or oral solution. Dosing is individualized and closely monitored through therapeutic drug monitoring (TDM) using blood trough level measurements. A typical maintenance dose for kidney transplant recipients ranges from 2 to 5 mg per day, though the exact dose is always determined by the treating physician.

Side Effects

Rapamycin can cause a range of side effects, particularly with long-term or high-dose use:

Increased risk of infections due to immunosuppression
Dyslipidemia (elevated triglycerides and cholesterol)
Impaired wound healing
Increased risk of certain cancers (e.g., non-melanoma skin cancer)
Non-infectious pneumonitis
Renal function impairment
Oral ulcers (stomatitis)

In non-approved uses such as self-experimentation for longevity purposes, rapamycin should only ever be used under close medical supervision.

Drug Interactions

Rapamycin is primarily metabolized by the hepatic enzyme CYP3A4. Therefore, numerous drugs and foods can significantly alter its blood concentration:

Increased levels: Azole antifungals (e.g., ketoconazole), macrolide antibiotics (e.g., clarithromycin), grapefruit juice
Decreased levels: Rifampicin, St. John's Wort, certain antiepileptic drugs

References

Saxton, R.A. & Sabatini, D.M. (2017): mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6), 960–976. doi:10.1016/j.cell.2017.02.004
Arriola Apelo, S.I. & Lamming, D.W. (2016): Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. The Journals of Gerontology, 71(7), 841–849.
European Medicines Agency (EMA): Rapamune (sirolimus) – Summary of Product Characteristics. Last updated 2023. Available at: www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category